EASDHIGHLIGHTS.COM: Keyword Density Checker

Total words: 4363 | 2-word phrases: 1119 | 3-word phrases: 1296 | 4-word phrases: 1377

PAGE INFO

Title	Try to keep the title under 60 characters (37 characters) EASD 2023 Medfyle Conference Coverage
Description	Try to keep the meta description between 50 - 160 characters (74 characters) Curated bite-sized summaries of key sessions with expert video commentary!
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (17 characters) EASD 2023 Medfyle

#	Keyword	Frequency	Density
1	type 2 diabetes	11	0.85%
2	type 2 diabetes?	11	0.85%
3	sglt2 inhibitors and	9	0.69%
4	inhibitors and glp1	8	0.62%
5	8 what	7	0.54%
6	and glp1 ras?	5	0.39%
7	and glp1 ras	5	0.39%
8	of type 2	4	0.31%
9	type 1 diabetes	4	0.31%
10	short oral presentations	4	0.31%
11	type 1 diabetes?	4	0.31%
12	the results of	4	0.31%
13	for type 2	3	0.23%
14	in collaboration with	3	0.23%
15	of sglt2 inhibitors	3	0.23%
16	medfyle conference coverage	3	0.23%
17	remission of type	3	0.23%
18	adverse effects on	3	0.23%
19	triple g agonist	3	0.23%
20	effects on muscle	3	0.23%
21	what were the	3	0.23%
22	autoimmune type 1	3	0.23%
23	were the key	3	0.23%
24	and glp1 related	3	0.23%
25	results of surmount4	3	0.23%
26	glp1 related therapies	3	0.23%
27	from short oral	3	0.23%
28	easd 2023short oral session	3	0.23%
29	from oral presentations	3	0.23%
30	do the results	3	0.23%

#	Keyword	Frequency	Density
1	sglt2 inhibitors and glp1	8	0.58%
2	of type 2 diabetes?	4	0.29%
3	of type 2 diabetes	4	0.29%
4	autoimmune type 1 diabetes?	3	0.22%
5	remission of type 2	3	0.22%
6	inhibitors and glp1 ras?	3	0.22%
7	of sglt2 inhibitors and	3	0.22%
8	what were the key	3	0.22%
9	adverse effects on muscle	3	0.22%
10	autoimmune type 1 diabetes	3	0.22%
11	for type 2 diabetes	3	0.22%
12	inhibitors and glp1 ras	3	0.22%
13	do the results of	3	0.22%
14	inhibitors and glp1 related	3	0.22%
15	the results of surmount4	3	0.22%
16	from short oral presentations	3	0.22%
17	to change daily practice?	2	0.15%
18	with inadequately controlled type	2	0.15%
19	maintenance of weight reduction	2	0.15%
20	inadequately controlled type 2	2	0.15%
21	interviews deep dives medfyle	2	0.15%
22	in people with inadequately	2	0.15%
23	8 what is	2	0.15%
24	8 what were	2	0.15%
25	8 what were the	2	0.15%
26	clinically relevant are the	2	0.15%
27	therapy with sglt2 inhibitors	2	0.15%
28	were the key findings	2	0.15%
29	and glp1 ras be	2	0.15%
30	easd 2023 medfyle conference	2	0.15%
31	2023 medfyle conference coverage	2	0.15%
32	do all sglt2 inhibitors	2	0.15%
33	potential to change daily	2	0.15%
34	supported by an educational	2	0.15%
35	without adverse effects on	2	0.15%
36	is supported by an	2	0.15%
37	activity is supported by	2	0.15%
38	were the key findings?	2	0.15%
39	benefits of sglt2 inhibitors	2	0.15%
40	people with inadequately controlled	2	0.15%

#	URL	Whois	Check
1	https://easd23.medfyle.com/faculty-interviews	Whois	medfyle.com
2	https://easd23.medfyle.com/deep-dives	Whois	medfyle.com
3	https://easd23.medfyle.com/user/library	Whois	medfyle.com
4	https://easd23.medfyle.com/tests/11	Whois	medfyle.com
5	https://easd23.medfyle.com	Whois	medfyle.com
6	https://easd23.medfyle.com	Whois	medfyle.com
7	https://easd23.medfyle.com/faculty-interviews	Whois	medfyle.com
8	https://easd23.medfyle.com/deep-dives	Whois	medfyle.com
9	https://easd23.medfyle.com/tests/11	Whois	medfyle.com
10	https://easd23.medfyle.com/user/library	Whois	medfyle.com
11	https://easd23.medfyle.com/credits	Whois	medfyle.com
12	https://easd23.medfyle.com/learning-objectives	Whois	medfyle.com
13	https://easd23.medfyle.com/privacy	Whois	medfyle.com
14	https://easd23.medfyle.com/cookies	Whois	medfyle.com
15	https://easd23.medfyle.com/contact	Whois	medfyle.com
16	https://easd23.medfyle.com/privacy	Whois	medfyle.com
17	https://medfyle.com/	Whois	medfyle.com
18	https://apps.apple.com/us/app/id1519341272	Whois	apple.com
19	https://play.google.com/store/apps/details?id=uk.co.globalport.medfyle	Whois	google.com
20	https://easd23.medfyle.com/privacy	Whois	medfyle.com
21	https://easd23.medfyle.com/cookies	Whois	medfyle.com